Recent years have witnessed groundbreaking developments in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://antonusiv473366.win-blog.com/19977153/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements